About ConforMIS

“ We believe that optimizing implant fit and performance requires a patient-specific approach. ”
No two knees are the same. No two ConforMIS knee implants are either.

Orthopedics has historically been a game of averages. Average sizes. Average shapes. Average results. No more.

We start with a simple idea: make the implant fit the patient rather then force the patient fit the implant

As the industry leader in patient-specific technology, ConforMIS does something that no other knee implant manufacturer has done. We put the patient at the center of implant design. By combining advanced 3D imaging technology with the latest manufacturing capabilities, we customize each and every implant to the patient’s unique size and shape.

Our Company

Founded in 2004, ConforMIS is a privately held company that develops and commercializes medical devices for the treatment of osteoarthritis and joint damage. ConforMIS transforms patient CT data into customized implants with a complete set of patient-specific instrumentation using its proprietary iFit® image-to-implant® technology. Its FDA-cleared partial and total knee replacement systems are sized and shaped to match each patient’s unique anatomy for the potential of a more natural feeling knee. The technology to create patient-specific implants and instruments is supported by a portfolio of over 375 patents and patent applications in the areas of image processing, patient-specific implant systems, patient-specific surgical techniques, patient-specific instrumentation, and manufacturing across multiple joints.

  • 2004
  • 2007
    Nov. 6, 2007: John Slamin, 30-year industry veteran, appointed Vice President of Implant Engineering
  • 2008
  • 2009
    Apr. 6, 2009: ConforMIS awarded a 2009 Medical Design Excellence Award (MDEA) for its minimally invasive, patient-specific iUni® and iDuo® partial knee implants
    Jun. 23, 2009: iDuo® receives CE Mark certification in all European Union markets
    Jul. 13, 2009: ConforMIS raises $50 million from private-equity and sovereign-wealth funds in the U.S. Asia, Europe and the Middle East
    Dec. 14, 2009: iUni® G2 launched in the United States
  • 2010
    Apr. 13, 2010: iUni® G2 receives CE Mark certification in all European Union markets
    Nov. 4, 2010: iDuo® G2 launched in United States
  • 2011
    Feb. 3, 2011: iTotal® CR receives 510(k) clearance from the United States Food and Drug Administration
    May 2011: first iTotal® cases
    Jun. 1, 2011: iTotal® CR receives CE Mark certification in all European Union markets
    Jun. 16, 2011: ConforMIS selected as winner for 2011 American Technology Award, recognizing the iTotal® knee replacement system for outstanding achievement
  • 2012
    Jan. 30, 2012: ConforMIS raises $89 million Series E financing round
    May 25, 2012: ConforMIS iTotal® CR knee replacement system wins Silver in 2012 Medical Design Excellence Awards
    Oct. 3, 2012: iTotal® G2 launched in the United States and European Union
    Nov. 12, 2012: Peter Traynor, a 30-year industry veteran, appointed Chief Financial Officer
  • 2013
    May 16, 2013: Matthew Scott appointed Senior Vice President of Operations
    Aug. 2, 2013: ConforMIS expands its Series E financing to $167.7 million